Vanda Pharmaceuticals VNDA
NASDAQ VNDA
$4.81 -0.10 (-2.04%)
At close: Oct 1, 2026 · 4:00 PM EDT

Vanda Pharmaceuticals (VNDA) Accounts Payables (2010 - 2026)

Updated

Vanda Pharmaceuticals (VNDA) reported Accounts Payables of $69.99 million for Q2 2026, up 22.5% from $57.12 million a year earlier and up 15.5% from the prior quarter.

Analysis

Vanda Pharmaceuticals (VNDA) Accounts Payables (2010 - 2026) Analysis & Trends

At the end of FY2025, Vanda Pharmaceuticals posted Accounts Payables of $68.3 million, up 74.7% from FY2024.

  • Accounts Payables has a five-year compound annual growth rate of 16.7% (FY2020 to FY2025).
  • By year, Accounts Payables came in at $39.09 million in FY2024 (+1.6%), $38.46 million in FY2023 (-15.6%), $45.55 million in FY2022 (+32.3%) and $34.44 million in FY2021 (+9.3%).
  • The Q2 2026 figure ranks as the highest quarterly Accounts Payables in data going back to Q4 2010.
  • Year over year, Accounts Payables has now increased in each of the last ten quarters, with growth averaging 29.8% over the last eight quarters.
  • The high point for year-over-year Accounts Payables in five years was Q1 2022 (growth of 96.9%); the low point was Q2 2023 (a decline of 36.4%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $60.62 million (Q1 2026), $68.3 million (Q4 2025) and $47.62 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 9.22 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 33.30 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 3.83 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 4.26 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -22.89 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 2.87 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 674.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.58 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 429.50 Mn
10 Vanda Pharmaceuticals 296.83 Mn -633.11 Mn 46.97 Mn 69.99 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 69.99 Mn
Mar 31, 2026 60.62 Mn
Dec 31, 2025 68.30 Mn
Sep 30, 2025 47.62 Mn
Jun 30, 2025 57.12 Mn
Mar 31, 2025 45.28 Mn
Dec 31, 2024 39.09 Mn
Sep 30, 2024 39.30 Mn
Jun 30, 2024 39.60 Mn
Mar 31, 2024 37.77 Mn
Dec 31, 2023 38.46 Mn
Sep 30, 2023 32.60 Mn
Jun 30, 2023 31.93 Mn
Mar 31, 2023 35.09 Mn
Dec 31, 2022 45.55 Mn
Sep 30, 2022 50.13 Mn
Jun 30, 2022 50.24 Mn
Mar 31, 2022 51.39 Mn
Dec 31, 2021 34.44 Mn
Sep 30, 2021 31.82 Mn
API Access

Vanda Pharmaceuticals Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=VNDA&period=max&api_key=YOUR_API_KEY